Washington / DC / Washington / D.C. / Washington / /
Company
C & D Data Group / Other Entities Part D Program Integrity Program / Medicare & Medicaid Services / Part D Plan Sponsor / Its Contractors / Other Entities Figure / /
Continent
America / /
Country
United States / /
Currency
USD / / /
Event
Business Partnership / /
Facility
Managed Care Pharmacy / /
IndustryTerm
stakeholder groups / work products / anti-fraud groups / law enforcement actions / federal health insurance program / law enforcement / health information technology / media reports / private insurers / /
Organization
federal government / HHS Office / Committee on Ways and Means / Prescription Drug Monitoring Programs Center for Excellence / National Association of Medicaid Fraud Control Units / House of Representatives / Federation of State Medical Boards / Subcommittee on Health / Special Investigation Unit / U.S. government / CMS’s Center for Program Integrity / Honorable Kevin Brady Chairman Subcommittee / American Medical Association / Committee on Ways and Means House of Representatives Dear / National Health Care Anti-Fraud Association / Academy of Managed Care Pharmacy / Department of Health and Human Services / Department of Health / National Association of Attorneys General / CMS’s CPI / American Pharmacists Association / National Association of Chain Drug Stores / National Community Pharmacists Association / Drug Enforcement Administration / Department of Health and Human Services office / office of Inspector General Overutilization Monitoring System Prescription Drug Monitoring Program Recovery Audit / Health Care Compliance Association / Pharmaceutical Care Management Association / MEDICARE / National Association of Medicaid Directors / /
Person
Kathleen M. King / / /
Position
Inspector General / Prescribers with Questionable Patterns / gov. United States Government Accountability Office Contents / Contractor / Chairman / Drug Integrity Contractor / physician / Inspector General / /
GAO-15-66, Medicare Program Integrity: CMS Pursues Many Practices to Address Prescription Drug Fraud, Waste, and Abuse